Araştırma Makalesi
BibTex RIS Kaynak Göster

The investigation of serum nectin-4 levels in patients with early onset preeclampsia

Yıl 2023, Cilt: 6 Sayı: 6, 1193 - 1199, 29.10.2023

Züat Acar Mehmet Obut Zeynep Gedik Özköse Sadun Sucu Salim Sezer Mevlüt Bucak İsmail Dağ Sezgi Güllü Erciyestepe İsmail Özdemir

https://doi.org/10.32322/jhsm.1350858

Öz

Aims: We aimed to investigate the level and predictive value of soluble nectin-4 in early onset preeclampsia (EOPE).
Methods: Forty-three patients with EOPE and 41 healthy normotensive pregnant women participated in this prospective case-control study. The groups were matched for gestational age and gravidity. Serum nectin-4 levels were compared between groups. The ROC curve was drawn to show the predictive value of nectin-4 for EOPE. Patients were followed up until the end of labor, and perinatal outcomes were recorded.
Results: The demographic characteristics of the two groups were similar. Serum nectin-4 level was significantly increased in EOPE cases compared to controls (226.46±119.6 ng/ml vs. 156.54±44.8 ng/ml, p=0.001). The ROC showed that at > 160.938, the sensitivity and specificity were 67.44% and 82.93%, respectively [AUC:0.822, (CI:0.724 - 0.897), and (p< 0.001)]. Significant inverse correlations were found between nectin-4 levels and poor obstetric outcomes.
Conclusion: Maternal serum nectin-4 levels were significantly higher in patients with EOPE compared with controls. Increased nectin-4 levels may contribute to the development of EOPE through possible oxidative, immunological, and inflammatory mechanisms adversely affecting trophoblastic cells.

Anahtar Kelimeler

Early preeclampsia nectin-4 preeclampsia pregnancy

Kaynakça

  • Gestational Hypertension and Preeclampsia: ACOG practice bulletin, number 222. Obstet Gynecol. 2020;135(6):e237.
  • Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol. 2013;209(6):544.e1-544.e12.
  • Harmon QE, Huang L, Umbach DM, et al. Risk of fetal death with preeclampsia. Obstet Gynecol. 2015;125(3):628-635.
  • Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res. 2019;124(7):1094-1112.
  • Redman CW, Sargent IL, Staff AC. IFPA Senior Award Lecture: making sense of pre-eclampsia - two placental causes of preeclampsia? Placenta. 2014;35 Suppl:S20-25.
  • Raymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv. 2011;66(8):497-506.
  • Obut M, Oğlak SC. Expression of CD44 and IL-10 in normotensive and preeclamptic placental tissue. Ginekol Pol. 2020;91(6):334-341.
  • Ito M, Nishizawa H, Tsutsumi M, et al. Potential role for nectin-4 in the pathogenesis of pre-eclampsia: a molecular genetic study. BMC Med Genet. 2018;19:166.
  • Wang Y, Walsh SW. TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas. J Reprod Immunol. 1996;32(2):157-169.
  • Reymond N, Fabre S, Lecocq E, Adelaïde J, Dubreuil P, Lopez M. Nectin4/PRR4, a new afadin-associated member of the nectin family that trans-interacts with nectin1/PRR1 through V domain interaction. J Biol Chem. 2001;276(46):43205-43215.
  • Adu-Gyamfi EA, Czika A, Gorleku PN, et al. The involvement of cell adhesion molecules, tight junctions, and gap junctions in human placentation. Reprod Sci Thousand Oaks Calif. 2021;28(2):305-320.
  • Fabre-Lafay S, Monville F, Garrido-Urbani S, et al. Nectin-4 is a new histological and serological tumor associated marker for breast cancer. BMC Cancer. 2007;7:73.
  • Karabulut M, Gunaldi M, Alis H, et al. Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma. Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex. 2016;18(2):160-171.
  • Zhou Y, Damsky CH, Chiu K, Roberts JM, Fisher SJ. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest. 1993;91(3):950-960.
  • Oudejans CBM, van Dijk M, Oosterkamp M, Lachmeijer A, Blankenstein MA. Genetics of preeclampsia: paradigm shifts. Hum Genet. 2007;120(5):607-612.
  • Esplin MS, Fausett MB, Fraser A, et al. Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med. 2001;344(12):867-872.
  • Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol. 2002;2(9):656-663.
  • Meggyes M, Nagy DU, Szigeti B, et al. Investigation of mucosal-associated invariant T (MAIT) cells expressing immune checkpoint receptors (TIGIT and CD226) in early-onset preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2020;252:373-381.
  • Hackmon R, Koifman A, Hyodo H, Glickman H, Sheiner E, Geraghty DE. Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia. Am J Obstet Gynecol. 2007;197(3):255.e1-5.
  • Steinborn A, Varkonyi T, Scharf A, Bahlmann F, Klee A, Sohn C. Early detection of decreased soluble HLA-G levels in the maternal circulation predicts the occurrence of preeclampsia and intrauterine growth retardation during further course of pregnancy. Am J Reprod Immunol NYN 1989. 2007;57(4):277-286.
  • Goswami D, Tannetta DS, Magee LA, et al. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta. 2006;27(1):56-61.
  • M-Rabet M, Cabaud O, Josselin E, et al. Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer. Ann Oncol Off J Eur Soc Med Oncol. 2017;28(4):769-776.
  • Reches A, Ophir Y, Stein N, et al. Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity. J Immunother Cancer. 2020;8(1):e000266.
  • Fu W, Ma Z, Lei C, Ding M, Hu S. TIGIT-Fc Promote Immune Tolerance at the Feto-maternal Interface [Internet]. bioRxiv. 2019:819243. doi: https://doi.org/10.1101/819243
  • Yu X, Harden K, Gonzalez LC, et al. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat Immunol. 2009;10(1):48-57.
  • Rzymski T, Petry A, Kračun D, et al. The unfolded protein response controls induction and activation of ADAM17/TACE by severe hypoxia and ER stress. Oncogene. 2012;31(31):3621-3634.
  • Gomaa MF, Naguib AH, Swedan KH, Abdellatif SS. Serum tumor necrosis factor-α level and uterine artery Doppler indices at 11-13 weeks’ gestation for preeclampsia screening in low-risk pregnancies: a prospective observational study. J Reprod Immunol. 2015;109:31-35.
  • Ma R, Gu Y, Groome LJ, Wang Y. ADAM17 regulates TNFα production by placental trophoblasts. Placenta. 2011;32(12):975-980.
  • Siddharth S, Nayak A, Das S, et al. The soluble nectin-4 ecto-domain promotes breast cancer induced angiogenesis via endothelial Integrin-β4. Int J Biochem Cell Biol. 2018;102:151-160.
  • Kim YN, Lee DS, Jeong DH, Sung MS, Kim KT. The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia. Prenat Diagn. 2009;29(5):464-470.
  • Maynard SE, Karumanchi SA. Angiogenic factors and preeclampsia. Semin Nephrol. 2011;31(1):33-46.
  • Hirashima C, Ohkuchi A, Matsubara S, et al. Alteration of serum soluble endoglin levels after the onset of preeclampsia is more pronounced in women with early-onset. Hypertens Res. 2008;31(8):1541-1548.
  • Hu T, Wang G, Zhu Z, Huang Y, Gu H, Ni X. Increased ADAM10 expression in preeclamptic placentas is associated with decreased expression of hydrogen sulfide production enzymes. Placenta. 2015;36(8):947-950.
  • Buchanan PC, Boylan KLM, Walcheck B, et al. Ectodomain shedding of the cell adhesion molecule nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17. J Biol Chem. 2017;292(15):6339-6351.
  • Yoshizawa H, Nishizawa H, Ito M, et al. Increased levels of nectin-4 as a serological marker for pre-eclampsia. Fujita Med J. 2023;9(3):200-205.

Yıl 2023, Cilt: 6 Sayı: 6, 1193 - 1199, 29.10.2023

Züat Acar Mehmet Obut Zeynep Gedik Özköse Sadun Sucu Salim Sezer Mevlüt Bucak İsmail Dağ Sezgi Güllü Erciyestepe İsmail Özdemir

https://doi.org/10.32322/jhsm.1350858

Öz

Kaynakça

  • Gestational Hypertension and Preeclampsia: ACOG practice bulletin, number 222. Obstet Gynecol. 2020;135(6):e237.
  • Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol. 2013;209(6):544.e1-544.e12.
  • Harmon QE, Huang L, Umbach DM, et al. Risk of fetal death with preeclampsia. Obstet Gynecol. 2015;125(3):628-635.
  • Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res. 2019;124(7):1094-1112.
  • Redman CW, Sargent IL, Staff AC. IFPA Senior Award Lecture: making sense of pre-eclampsia - two placental causes of preeclampsia? Placenta. 2014;35 Suppl:S20-25.
  • Raymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv. 2011;66(8):497-506.
  • Obut M, Oğlak SC. Expression of CD44 and IL-10 in normotensive and preeclamptic placental tissue. Ginekol Pol. 2020;91(6):334-341.
  • Ito M, Nishizawa H, Tsutsumi M, et al. Potential role for nectin-4 in the pathogenesis of pre-eclampsia: a molecular genetic study. BMC Med Genet. 2018;19:166.
  • Wang Y, Walsh SW. TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas. J Reprod Immunol. 1996;32(2):157-169.
  • Reymond N, Fabre S, Lecocq E, Adelaïde J, Dubreuil P, Lopez M. Nectin4/PRR4, a new afadin-associated member of the nectin family that trans-interacts with nectin1/PRR1 through V domain interaction. J Biol Chem. 2001;276(46):43205-43215.
  • Adu-Gyamfi EA, Czika A, Gorleku PN, et al. The involvement of cell adhesion molecules, tight junctions, and gap junctions in human placentation. Reprod Sci Thousand Oaks Calif. 2021;28(2):305-320.
  • Fabre-Lafay S, Monville F, Garrido-Urbani S, et al. Nectin-4 is a new histological and serological tumor associated marker for breast cancer. BMC Cancer. 2007;7:73.
  • Karabulut M, Gunaldi M, Alis H, et al. Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma. Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex. 2016;18(2):160-171.
  • Zhou Y, Damsky CH, Chiu K, Roberts JM, Fisher SJ. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest. 1993;91(3):950-960.
  • Oudejans CBM, van Dijk M, Oosterkamp M, Lachmeijer A, Blankenstein MA. Genetics of preeclampsia: paradigm shifts. Hum Genet. 2007;120(5):607-612.
  • Esplin MS, Fausett MB, Fraser A, et al. Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med. 2001;344(12):867-872.
  • Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol. 2002;2(9):656-663.
  • Meggyes M, Nagy DU, Szigeti B, et al. Investigation of mucosal-associated invariant T (MAIT) cells expressing immune checkpoint receptors (TIGIT and CD226) in early-onset preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2020;252:373-381.
  • Hackmon R, Koifman A, Hyodo H, Glickman H, Sheiner E, Geraghty DE. Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia. Am J Obstet Gynecol. 2007;197(3):255.e1-5.
  • Steinborn A, Varkonyi T, Scharf A, Bahlmann F, Klee A, Sohn C. Early detection of decreased soluble HLA-G levels in the maternal circulation predicts the occurrence of preeclampsia and intrauterine growth retardation during further course of pregnancy. Am J Reprod Immunol NYN 1989. 2007;57(4):277-286.
  • Goswami D, Tannetta DS, Magee LA, et al. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta. 2006;27(1):56-61.
  • M-Rabet M, Cabaud O, Josselin E, et al. Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer. Ann Oncol Off J Eur Soc Med Oncol. 2017;28(4):769-776.
  • Reches A, Ophir Y, Stein N, et al. Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity. J Immunother Cancer. 2020;8(1):e000266.
  • Fu W, Ma Z, Lei C, Ding M, Hu S. TIGIT-Fc Promote Immune Tolerance at the Feto-maternal Interface [Internet]. bioRxiv. 2019:819243. doi: https://doi.org/10.1101/819243
  • Yu X, Harden K, Gonzalez LC, et al. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat Immunol. 2009;10(1):48-57.
  • Rzymski T, Petry A, Kračun D, et al. The unfolded protein response controls induction and activation of ADAM17/TACE by severe hypoxia and ER stress. Oncogene. 2012;31(31):3621-3634.
  • Gomaa MF, Naguib AH, Swedan KH, Abdellatif SS. Serum tumor necrosis factor-α level and uterine artery Doppler indices at 11-13 weeks’ gestation for preeclampsia screening in low-risk pregnancies: a prospective observational study. J Reprod Immunol. 2015;109:31-35.
  • Ma R, Gu Y, Groome LJ, Wang Y. ADAM17 regulates TNFα production by placental trophoblasts. Placenta. 2011;32(12):975-980.
  • Siddharth S, Nayak A, Das S, et al. The soluble nectin-4 ecto-domain promotes breast cancer induced angiogenesis via endothelial Integrin-β4. Int J Biochem Cell Biol. 2018;102:151-160.
  • Kim YN, Lee DS, Jeong DH, Sung MS, Kim KT. The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia. Prenat Diagn. 2009;29(5):464-470.
  • Maynard SE, Karumanchi SA. Angiogenic factors and preeclampsia. Semin Nephrol. 2011;31(1):33-46.
  • Hirashima C, Ohkuchi A, Matsubara S, et al. Alteration of serum soluble endoglin levels after the onset of preeclampsia is more pronounced in women with early-onset. Hypertens Res. 2008;31(8):1541-1548.
  • Hu T, Wang G, Zhu Z, Huang Y, Gu H, Ni X. Increased ADAM10 expression in preeclamptic placentas is associated with decreased expression of hydrogen sulfide production enzymes. Placenta. 2015;36(8):947-950.
  • Buchanan PC, Boylan KLM, Walcheck B, et al. Ectodomain shedding of the cell adhesion molecule nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17. J Biol Chem. 2017;292(15):6339-6351.
  • Yoshizawa H, Nishizawa H, Ito M, et al. Increased levels of nectin-4 as a serological marker for pre-eclampsia. Fujita Med J. 2023;9(3):200-205.
Toplam 35 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Kadın Hastalıkları ve Doğum
Bölüm Orijinal Makale
Yazarlar

Züat Acar 0000-0002-3485-1554

Mehmet Obut 0000-0002-6925-4784

Zeynep Gedik Özköse 0000-0001-6662-8042

Sadun Sucu 0000-0003-3758-0136

Salim Sezer 0000-0003-1287-4306

Mevlüt Bucak 0000-0002-5035-8727

İsmail Dağ 0000-0002-9432-7965

Sezgi Güllü Erciyestepe 0000-0001-5337-5461

İsmail Özdemir 0000-0002-9043-1431

Erken Görünüm Tarihi 28 Ekim 2023
Yayımlanma Tarihi 29 Ekim 2023
Yayımlandığı Sayı Yıl 2023 Cilt: 6 Sayı: 6

Kaynak Göster

AMA Acar Z, Obut M, Gedik Özköse Z, Sucu S, Sezer S, Bucak M, Dağ İ, Erciyestepe SG, Özdemir İ. The investigation of serum nectin-4 levels in patients with early onset preeclampsia. J Health Sci Med /JHSM /jhsm. Ekim 2023;6(6):1193-1199. doi:10.32322/jhsm.1350858
 Kapak Resmi İndir

Üniversitelerarası Kurul (ÜAK) Eşdeğerliği:  Ulakbim TR Dizin'de olan dergilerde yayımlanan makale [10 PUAN] ve 1a, b, c hariç  uluslararası indekslerde (1d) olan dergilerde yayımlanan makale [5 PUAN]

Dahil olduğumuz İndeksler (Dizinler) ve Platformlar sayfanın en altındadır.

Not: Dergimiz WOS indeksli değildir ve bu nedenle Q olarak sınıflandırılmamıştır.

Yüksek Öğretim Kurumu (YÖK) kriterlerine göre yağmacı/şüpheli dergiler hakkındaki kararları ile yazar aydınlatma metni ve dergi ücretlendirme politikasını tarayıcınızdan indirebilirsiniz. https://dergipark.org.tr/tr/journal/2316/file/4905/show 


Dergi Dizin ve Platformları

Dizinler; ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, vs.

Platformlar; Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons vs.